Please login to the form below

Not currently logged in
Email:
Password:

EBE

This page shows the latest EBE news and features for those working in and with pharma, biotech and healthcare.

Industry welcomes European diagnostics regulations

Industry welcomes European diagnostics regulations

scandal. The European Biopharmaceutical Enterprises (EBE) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) voiced qualified support for the new IVD regulations. ... Barbara Freischem, executive director of EBE, commented:

Latest news

  • EMA on track with biosimilars guidance says industry EMA on track with biosimilars guidance says industry

    Trade organisations the European Biopharmaceutical Enterprises (EBE) and EuropaBio believe the planned revisions "offer important developments to further strengthen the biosimilars pathway in Europe", according to Eugene Corretge, strategic unit

  • Orphan drug legislation hailed as success

    Legislation governing Orphan Medicinal Products in Europe has had a positive impact, according to a joint EBE and EuropaBio task force. ... EBE (European Biopharmaceutical Enterprises) and EuropaBio's Joint Rare Diseases and Orphan Medicinal Products

  • What is EFPIA...

    EFPIA has two specialist groups to address specific issues. The European Vaccine Manufacturers (EVM) covers vaccine topics, while European Biotechnology Enterprises (EBE) deals with the needs of biopharmaceutical sector companies.

  • The mothership

    Therefore please make your contributions to your European Trade Association; be it EVM for vaccine manufacturers, Eucomed for medical device manufacturers, EBE for upcoming biopharmaceutical companies, or the mothership itself, EFPIA,

  • A model approach A model approach

    The European Biopharmaceutical Enterprises (EBE) has requested that the EC and the EMEA issue guidance and clarify the concepts of 'similarity', 'interchangeability' and 'substitution'. ... The EBE considers this to be crucial for industry and healthcare

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest appointments

  • Eduardo Bravo becomes head of EBE Eduardo Bravo becomes head of EBE

    TiGenix CEO appointed president of the EBE’s board of directors. The European Biopharmaceutical Enterprises (EBE) has appointed Eduardo Bravo as president of its board of directors for the 2016-2018 ... 2011. Barbara Freischem, EBE's executive director,

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics